Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Rexista is definitely an authorized generic(NDA) and Purdue already lost its patent challenge against Collegium as you and everyone here already knows. Purdue also lost its case against 4 other co's bringing generic forms of oxy to market and had all 4 of their oxy patent challenges tossed and all appeals dismissed.

In fact Purdue's last grasp at the straw ended when they attempted to re-open the oxy patent challenges with the United States Supreme Court last year only to have the Supreme Court shut down any further patent challenges on their 4 oxy patent challenges just 2 months ago in November 2016.

So although I'm certainly no attorney...I tend to lean towards Angelo's belief that Rexista will speed through the NDA approval process with no lawsuit from Purdue...because even if Purdue files a lawsuit at this incredibly late juncture it will be immediately dismissed by the courts because the courts have already deemed Purdue's oxy patent challenges invalid all the way up to the very top of the Supreme Court ladder.

I've never called IPCI to ask them about any potential Purdue lawsuits...but unlike Collegium which Purdue filed a lawsuit against as soon as Collegium submitted their NDA...we've seen no such lawsuit filed against IPCI after IPCI submitted their NDA on November 25th right...which interestingly enough was about 2 weeks after the US Supreme Court denied Purdue any last grasp attempts at re-opening the 4 oxy patent challenges they lost against other companies.

You being an attorney know far more about the potential lawsuit landscape than I do however...so I will defer to your legal expertise on that possibility/in that entire area